Provided by Tiger Trade Technology Pte. Ltd.

Verve Therapeutics

11.13
0.0000
Volume:- -
Turnover:114.94M
Market Cap:994.14M
PE:-5.30
High:11.13
Open:11.13
Low:11.13
Close:11.13
52wk High:11.41
52wk Low:2.86
Shares:89.32M
Float Shares:65.50M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1013
EPS(LYR):-2.3454
ROE:-34.26%
ROA:-19.35%
PB:2.10
PE(LYR):-4.75

Loading ...

BRIEF-Lilly To Acquire Verve Therapeutics To Advance One-Time Treatments For People With High Cardiovascular Risk

Reuters
·
Jun 17, 2025

This five-star fund manager says even smart investors have been missing the greatest theme of our time

Dow Jones
·
Jun 17, 2025

U.S. Stocks to Watch: AMD, Nvidia, Sunrun, Regencell, Verve Therapeutics, SRM, Houston American, and More

Dow Jones
·
Jun 17, 2025

Verve Therapeutics Soars 82% Following Report of $1.3B Eli Lilly Takeover Talks

Tiger Newspress
·
Jun 17, 2025

Stock Track | Verve Therapeutics Skyrockets 80.70% Pre-market on Potential $1.3 Billion Eli Lilly Acquisition

Stock Track
·
Jun 17, 2025

Verve Therapeutics Stock Soars 75% as Eli Lilly Nears $1.3 Billion Deal for the Gene-Editing Biotech

Reuters
·
Jun 17, 2025

BRIEF-Eli Lilly Close To Buying Gene-Editing Biotech Verve Therapeutics - FT

Reuters
·
Jun 17, 2025

Verve Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 11, 2025

BRIEF-Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Jun 03, 2025

Verve Therapeutics Announces New Equity Awards for Employees Under 2024 Inducement Stock Incentive Plan

Reuters
·
Jun 03, 2025

Verve Therapeutics Q1 EPS $(0.35) Versus $(0.59) YoY, Sales $32.98M

Benzinga
·
May 14, 2025

BRIEF-Verve Therapeutics Q1 Collaboration Revenue USD 32.976 Million

Reuters
·
May 14, 2025

Verve Therapeutics Reports Q1 2025 Collaboration Revenue Surge to $33M, Driven by Vertex Collaboration Termination Recognition

Reuters
·
May 14, 2025

Press Release: Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

Dow Jones
·
May 14, 2025